slide 1 of 1

WEBINAR

Real-world evidence for regulatory decision-making, in the era of COVID-19

Speakers

Jeremy Rassen

Jeremy Rassen, Sc.D.

Co-Founder, President, and Chief Science Officer, Aetion

Sebastian Schneeweiss

Sebastian Schneeweiss, M.D., Sc.D.

Professor of Medicine and Epidemiology, Harvard Medical School/Brigham and Women's Hospital 

What you'll learn

icon-learn

How RWE can help fill evidence gaps in the current global environment to ensure patients receive safe and effective treatments with minimal delay.

icon-learn

Which data sources, methods, and processes support the generation of regulatory-grade RWE.

icon-learn

How external control arms derived from RWD can be used in regulatory approvals where RCTs are not ethical or feasible, e.g., in oncology and rare diseases.

icon-learn

Considerations for using RWD sources to address questions about COVID-19 treatment approaches.

icon-covid

Watch Now

Listen as Drs. Rassen and Schneeweiss discuss opportunities for RWE amidst the COVID-19 pandemic.